CBIO - Catalyst Biosciences GAAP EPS of -$0.46 misses by $0.02 revenue of $0.8M
Catalyst Biosciences press release (NASDAQ:CBIO): Q1 GAAP EPS of -$0.46 misses by $0.02. Revenue of $0.8M (-45.6% Y/Y). Cash and cash equivalents as of March 31, 2022, were $34.8 million. Shares -4.99% PM.
For further details see:
Catalyst Biosciences GAAP EPS of -$0.46 misses by $0.02, revenue of $0.8M